Kongpakwattana K.; Ademi Z.; Chaiyasothi T.; Nathisuwan S.; Zomer E.; Liew D.; Chaiyakunapruk N.
(2019)
Background: Using non-statin lipid-modifying agents in combination with statin therapy provides additional benefits for cardiovascular disease (CVD) risk reduction, but their value for money has only been evaluated in ...